openPR Logo
Press release

COVID-19 Drug Associated APIs Market Size, Major Drivers, Trends And Analysis Report 2024-2033

03-18-2024 08:42 AM CET | Health & Medicine

Press release from: The Business research company

COVID-19 Drug Associated APIs Market

COVID-19 Drug Associated APIs Market

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033.

The Business Research Company offers in-depth market insights through COVID-19 Drug Associated APIs Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The covid-19 drug associated apis market size has grown strongly in recent years. It will grow from $6.37 billion in 2023 to $6.75 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to rising prevalence of covid-19, increasing awareness of covid-19 treatment options, expanding access to covid-19 drugs, growing demand for covid-19 drugs for prophylaxis, government initiatives, supply chain resilience.

The covid-19 drug associated apis market size is expected to see strongly grown in the next few years. It will grow to $8.52 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to development of new covid-19 drug modalities, increasing clinical trials for covid-19 drugs, rising demand for covid-19 vaccines, emerging variants, vaccination campaigns, pandemic preparedness. Major trends in the forecast period include customized api production, diversification of api sources, advanced manufacturing technologies, digitalization and data analytics, sustainability and green chemistry.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=3248&type=smp

Market Segmentation:
The covid-19 drug associated apis market covered in this report is segmented -
1) By Drug Class: Antimalarials, Bronchodilators, Antibiotics, Antivirals, Other Drug Class
2) By Synthesis Type: Synthetic, Biotech
3) By Business Mode: Captive API, Merchant API

Major Driver - Elevated Demand For Active Pharmaceutical Ingredients (APIS) Driven By Antivirals, Antimalarials, And Respiratory Medications In The Covid-19 Drug Market
High demand for antiretrovirals, antimalarials, sedatives, bronchodilators, and other respiratory drugs drives the demand for the active pharmaceutical ingredients (APIs) used in the production of COVID-19 drugs. Active pharmaceutical ingredients (APIs) are the biologically active components used in manufacturing pharmaceutical drugs. Remdesivir and Favipiravir are two common antiviral medications used currently for the treatment of COVID-19 patients. Remdesivir is a medication approved for emergency use in the USA and Japan for the treatment of COVID-19 patients. FDA has approved Airsupra (albuterol and budesonide) inhalation aerosol for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in patients with asthma 18 years of age and older. Favipiravir, which is used to treat influenza in Japan, has also shown a positive effect on COVID-19 patients. As COVID-19 is a respiratory ailment, the demand for bronchodilators spiked significantly. Therefore, the increasing demand for antivirals, antimalarials, and bronchodilators is projected to boost the demand for the COVID-19 drug associated APIs market over the forecast period.

Competitive Landscape:
Major companies operating in the covid-19 drug associated apis market include Dr. Reddy's Laboratories Ltd., Lianyungang Guike Pharmaceutical CO. LTD., Alembic Pharmaceuticals Ltd., Wockhardt Ltd., Sandoz Srl, Lupin Limited, Aurobindo Pharma Ltd., Shanghai Shyndec Pharmaceutical Co. Ltd., Zhejiang Yatai Pharmaceutical Co. Ltd., Zhejiang Guobang Pharmaceutical Co Ltd., Cipla Limited, Shandong Boyuan Pharmaceutical Co. Ltd., Aspiro Pharma Ltd., Qilu Antibiotics Pharmaceutical Co. Ltd., Shenzhen China Resources Jiuxin Pharmaceutical Co. Ltd., Zhejiang Cheng Yi Pharmaceutical, Star Lake Bioscience Co.Inc., Hetero Labs Ltd., Geno Pharmaceuticals Ltd., Mylan Laboratories Ltd., Ipca Laboratories Limited, Zydus Takeda Healthcare Private Limited, Mangalam Drugs & Organics, Wallace Pharmaceuticals, Zhejiang Hisun Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Zhejiang Jiuzhou Pharmaceutical Co. Ltd., Zhejiang NHU Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Zhejiang Yongtai Technology Co. Ltd., Zhejiang Zhebei Pharmaceutical Co. Ltd., Zhejiang Tianyu Pharmaceutical Co. Ltd., Zhejiang Aisheng Pharmaceutical Co. Ltd., Zhejiang Aokang Pharmaceutical Co. Ltd., Zhejiang Anji Huifeng Surgical Dressings Co. Ltd.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report

Top Trend - Pharmaceutical Industry's Strategic Expansion In Api Production To Meet Surging Demand For Covid-19 Drugs
Key players operating in the pharmaceutical industry that manufacture COVID-19 drug-associated APIs are focusing on strategies such as plant capacity or production capacity expansion to meet the increasing demand due to the rising number of coronavirus cases across the globe. For instance, in October 2023, Merck & Co., Inc., a US-based pharmaceutical company, with a recent partnership with the Heavy Water Board in India, hopes to tap into the deuterated raw compound industry, which is presently worth around $100 million and has the potential to rise to $1 billion over the next five to ten years. Merck seeks to support India's chemical, pharmaceutical, and technical sectors by offering high-quality compounds for the manufacture of medicines, semiconductors, OLEDs, and electronics. Avigan is currently undergoing clinical trials testing its safety and efficacy for the treatment of COVID-19 patients.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. COVID-19 Drug Associated APIs Market Characteristics
3. COVID-19 Drug Associated APIs Market Trends And Strategies
4. COVID-19 Drug Associated APIs Market - Macro Economic Scenario
5. COVID-19 Drug Associated APIs Market Size And Growth
…..
27. COVID-19 Drug Associated APIs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COVID-19 Drug Associated APIs Market Size, Major Drivers, Trends And Analysis Report 2024-2033 here

News-ID: 3433372 • Views:

More Releases from The Business research company

Leading Companies Enhancing Their Presence in the Wood Adhesives Market
Leading Companies Enhancing Their Presence in the Wood Adhesives Market
The wood adhesives market is positioned for considerable expansion over the coming years, driven by evolving demands and innovative applications across multiple sectors. As sustainability and advanced construction methods gain momentum, this market presents promising growth prospects shaped by technological advancements and environmental consciousness. Projected Growth and Market Size for Wood Adhesives by 2029 The wood adhesives industry is forecasted to grow impressively, reaching a market size of $7.58 billion by
Global Trends Overview: The Rapid Evolution of the Synthetic Gypsum Market
Global Trends Overview: The Rapid Evolution of the Synthetic Gypsum Market
The synthetic gypsum market is gaining momentum as industries increasingly focus on sustainable materials and environmental solutions. As infrastructure and agricultural sectors develop alongside growing recycling efforts, synthetic gypsum is set to play a vital role in multiple applications. Let's explore the current market size, key players, influential trends, and segmentation shaping this industry's future. Projected Market Size and Growth Outlook for Synthetic Gypsum The synthetic gypsum market is anticipated to
Sodium Lauryl Ether Sulfate (SLES) Market Overview, Key Trends, and Top Company Analysis
Sodium Lauryl Ether Sulfate (SLES) Market Overview, Key Trends, and Top Company …
The sodium lauryl ether sulfate (SLES) market is poised for notable expansion in the coming years, driven by increasing demand across several key industries. Rising awareness of eco-friendly products and innovations in personal care formulations are contributing to this upward trend. Let's explore the market's size projections, major companies, emerging trends, and key segmentation to get a comprehensive overview of the global SLES landscape. Projected Growth and Market Size of the
Leading Companies Enhancing Their Presence in the Refrigerants Market
Leading Companies Enhancing Their Presence in the Refrigerants Market
The refrigerants market is on track for substantial growth as global environmental and technological shifts reshape demand. With increasing regulations and changing consumer preferences, this sector is poised for notable expansion and innovation in the coming years. Let's explore the market's projected value, key players, emerging trends, and influential segments shaping its future. Projected Market Value and Growth Trajectory of the Refrigerants Market The refrigerants market is anticipated to expand significantly,

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the